Marksans Pharma Ltd - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2021 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company. MARKSANS PHARMA LTD. - 524404 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer MARKSANS PHARMA LTD. - 524404 - Closure of Trading Window
In terms of the Company''s Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the designated persons of the Company will remain closed from Friday, 1st October, 2021 till 48 hours after the declaration of unaudited financial results for the quarter and half-year ended 30th September, 2021. The date of declaration of financial results will be intimated separately in due course of time. Designated Persons of the Company and/or their immediate relatives shall not trade in the securities of the Company during the aforesaid period of closure of trading window. MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Marksans Pharma Ltd - 524404 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Marksans Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Marksans Pharma Ltd - 524404 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find enclosed herewith the results of the voting conducted through remote e-voting during 20th September, 2021 to 22nd September, 2021 (both days inclusive) and through e-voting during the AGM of Marksans Pharma Limited held today i.e. 23rd September, 2021 through video conferencing/ other audio visual means (VC) along with Consolidated report of the Scrutinizer. Marksans Pharma Ltd - 524404 - Proceedings Of The 29Th Annual General Meeting Of Marksans Pharma Limited Held On Thursday, September 23, 2021
This is to inform you that the 29th Annual General Meeting of Marksans Pharma Limited was held today i.e. Thursday, 23rd September, 2021 at 09:00 A.M. through Video Conferencing and the businesses mentioned in the Notice dated August 11, 2021 were transacted. Marksans Pharma Ltd - 524404 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of the 29th Annual General Meeting held on Thursday, 23rd September, 2021. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith Notice of 29th AGM, Book closure and e-voting information published today i.e. 1st September, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.